Association between endothelin type A receptor haplotypes and mortality in coronary heart disease

Papers of special note have been highlighted as: ▪ of interest

References

• 1  Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. Am. J. Cardiol.79(12B),17–23 (1997).▪ Review on the pathogenesis of acute coronary syndromes.
  Medline CASGoogle Scholar
• 2  Omland T, Persson A, Ng L et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation106(23),2913–2918 (2002).
  Medline CASGoogle Scholar
• 3  Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature332(6163),411–415 (1988).
  Medline CASGoogle Scholar
• 4  Inoue A, Yanagisawa M, Kimura S et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl Acad. Sci. USA86(8),2863–2867 (1989).
  Medline CASGoogle Scholar
• 5  Hocher B, Thone-Reineke C, Bauer C, Raschack M, Neumayer HH. The paracrine endothelin system: pathophysiology and implications in clinical medicine. Eur. J. Clin. Chem. Clin. Biochem.35(3),175–189 (1997).
  Medline CASGoogle Scholar
• 6  Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol.61,391–415 (1999).
  Medline CASGoogle Scholar
• 7  Wang QD, Hemsen A, Li XS, Lundberg JM, Uriuda Y, Pernow J. Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine. Cardiovasc. Res.29(1),44–49 (1995).
  MedlineGoogle Scholar
• 8  Benjafield AV, Katyk K, Morris BJ. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension. Clin. Genet.64(5),433–438 (2003).
  Medline CASGoogle Scholar
• 9  Rahman T, Baker M, Hall DH, Avery PJ, Keavney B. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure: a family study. J. Hum. Hypertens.22(4),282–288 (2008).▪ Large scale, family-based genetic association study investigating the role of polymorphisms in the EDNRA gene and blood pressure measured as a quantitative trait.
  Medline CASGoogle Scholar
• 10  Ormezzano O, Poirier O, Mallion JM et al. A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J. Hypertens.23(11),2019–2026 (2005).
  Medline CASGoogle Scholar
• 11  Nicaud V, Poirier O, Behague I et al. Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Temoins sur l’Infarctus du Myocarde (ECTIM) study. Am. J. Hypertens.12(3),304–310 (1999).
  Medline CASGoogle Scholar
• 12  Charron P, Tesson F, Poirier O et al. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur. Heart J.20(21),1587–1591 (1999).
  Medline CASGoogle Scholar
• 13  Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alperovitch A. Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. Neurology56(10),1273–1277 (2001).
  Medline CASGoogle Scholar
• 14  The international hapmap consortium: the international HapMap project. Nature426(6968),789–796 (2003).
  Medline CASGoogle Scholar
• 15  Johnson GC, Esposito L, Barratt BJ et al. Haplotype tagging for the identification of common disease genes. Nat. Genet.29(2),233–237 (2001).
  Medline CASGoogle Scholar
• 16  Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science296(5576),2225–2229 (2002).
  Medline CASGoogle Scholar
• 17  Cannon CP, Mccabe CH, Wilcox RG et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation102(2),149–156 (2000).
  Medline CASGoogle Scholar
• 18  De Lemos JA, Morrow DA, Bentley JH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med.345(14),1014–1021 (2001).
  Medline CASGoogle Scholar
• 19  Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. J. Cardiovasc. Pharmacol.31(1),116–125 (1998).
  Medline CASGoogle Scholar
• 20  Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin. Endocrinol. (Oxf.)47(3),287–296 (1997).
  Medline CASGoogle Scholar
• 21  Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J. Am. Soc. Echocardiogr.2(5),358–367 (1989).
  Medline CASGoogle Scholar
• 22  Palmer BR, Pilbrow AP, Yandle TG et al. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. J. Am. Coll. Cardiol.41(5),729–736 (2003).
  Medline CASGoogle Scholar
• 23  Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics21(2),263–265 (2005).
  Medline CASGoogle Scholar
• 24  Tobler AR, Short S, Andersen MR et al. The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J. Biomol. Tech.16(4),398–406 (2005).
  MedlineGoogle Scholar
• 25  De La Vega FM, Lazaruk KD, Rhodes MD, Wenz MH. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP genotyping assays and the SNPlex genotyping system. Mutat. Res.573(1–2),111–135 (2005).
  Medline CASGoogle Scholar
• 26  Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet.76(3),449–462 (2005).
  Medline CASGoogle Scholar
• 27  Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet.68(4),978–989 (2001).
  Medline CASGoogle Scholar
• 28  Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol.41,851–876 (2001).▪ Review on the endothelin system.
  Medline CASGoogle Scholar
• 29  Asai T, Ohkubo T, Katsuya T et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama study. Hypertension38(6),1321–1324 (2001).
  Medline CASGoogle Scholar
• 30  Iemitsu M, Maeda S, Otsuki T et al. Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects. Hypertension47(5),928–936 (2006).
  Medline CASGoogle Scholar
• 31  Mather KJ, Lteif A, Steinberg HO, Baron AD. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes53(8),2060–2066 (2004).
  Medline CASGoogle Scholar
• 32  Mather KJ, Mirzamohammadi B, Lteif A, Steinberg HO, Baron AD. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and Type 2 diabetes. Diabetes51(12),3517–3523 (2002).▪ Study highlighting the importance of endothelin-1 in contributing to vascular tone and endothelial dysfunction.
  Medline CASGoogle Scholar
• 33  Lteif A, Vaishnava P, Baron AD, Mather KJ. Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes56(3),728–734 (2007).
  Medline CASGoogle Scholar